Immunotherapy harnesses the body's immune system to combat cancer by stimulating or enhancing its natural defenses. Approaches include checkpoint inhibitors, which release immune brakes that cancer cells exploit to evade detection; monoclonal antibodies that tag cancer cells for destruction by immune cells; and adoptive cell transfer therapies like CAR T- cell therapy, where T-cells are genetically engineered to target specific cancer markers. Immunotherapy aims to activate immune responses against cancer cells, offering potential for long-term remission and fewer side effects compared to traditional treatments like chemotherapy. Ongoing research focuses on improving efficacy, broadening applicability across cancer types, and overcoming resistance mechanisms.
Tracks:
Checkpoint Inhibitors
Monoclonal Antibodies
CAR T-cell Therapy
Combination Therapies